Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

被引：0
|
作者：
Sahin, U. [1 ]
Merter, M. [1 ]
Atesagaoglu, B. [1 ]
Erdai, H. [2 ]
Bozdag, S. Civriz [1 ]
Toprak, S. K. [1 ]
Yuksel, M. Kurt [1 ]
Topcuoglu, P. [1 ]
Arslan, O. [1 ]
Ozcan, M. [1 ]
Demirer, T. [1 ]
Ilhan, O. [1 ]
Akan, H. [1 ]
Beksac, M. [1 ]
Konuk, N. [1 ]
Gurman, G. [1 ]
机构：
[1] Ankara Univ, Fac Med, Hematol & Bone Marrow Transplantat Unit, TR-06100 Ankara, Turkey
[2] Ankara Univ, Fac Med, Internal Med, TR-06100 Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P731
引用
收藏
页码：S483 / S483
页数：1
相关论文
共 50 条
  • [31] Potential candidates for CMV prophylaxis considering serological status in allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Jimenez Julia, Sara Aida
    Bento, Leyre
    Gutierrez, Antonio
    Barron, Ruben
    Gines, Jordi
    Novo, Andres
    Reina, Jordi
    Luis Perez, Jose
    Sampol, Antonia
    BONE MARROW TRANSPLANTATION, 2018, 53 : 577 - 578
  • [32] CYTOMEGALOVIRUS INFECTION IN PATIENTS WHO UNDERWENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): A SINGLE-CENTER EXPERIENCE
    Pardo Gambarte, Laura
    Cornago Navascues, Javier
    Sanchez de la Fuente, Monica
    Lopez Lorenzo, Jose Luis
    Solan Blanco, Laura
    LLamas Sillero, Pilar
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 431 - 431
  • [33] Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for 67 Pediatric Patients with High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Liu, De-Yan
    Cao, Xing-Yu
    Zhang, Jian-Ping
    Xiong, Min
    Zhao, Yan-Li
    Zhou, Jia-Rui
    Lu, Yue
    Lu, Pei-Hua
    Lu, DaoPei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [34] Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) with high-risk cytogenetics: a retrospective single-center study
    Heptner, B.
    Mikesch, J. -H.
    Reicherts, C.
    Groth, C.
    Call, S.
    Fueller, M.
    Albring, J. C.
    Schliemann, C.
    Kessler, T.
    Mesters, R.
    Berdel, W. E.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 60 - 60
  • [35] RISK FACTORS FOR THE DEVELOPMENT OF GRAFT VERSUS HOST DISEASE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANPLANTATION (allo-HSCT)
    Hamilton, B. K.
    Bolwell, B. Y.
    Rybicki, L.
    Kalaycio, M.
    Tench, S.
    Hanna, R.
    Duong, H.
    Sobecks, R.
    Pohlman, B.
    Andresen, S.
    Copelan, E. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S367 - S368
  • [36] Comparison of therapeutic effect between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of leukemia.
    Liu, Qifa
    Yang, Kai
    Fan, Zhiping
    Sun, Jing
    Xu, Dan
    Wei, Yongqiang
    Zhang, Yu
    Meng, Fanyi
    BLOOD, 2006, 108 (11) : 441B - 441B
  • [37] Influence of HLA alleles on the occurence of cytomegalovirus (CMV) infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
    Kakkas, I
    Tarassi, E
    Baltathakis, I
    Athanasiades, T
    Harhalakis, N
    Karakassis, D
    Anagnostopoulou, M
    Paniara, O
    Nikiforakis, E
    Papasteriades, C
    BLOOD, 2002, 100 (11) : 630A - 630A
  • [38] Rare minimal residual disease (MRD) and small amount of carrier lymphocytes in adult T cell leukemia/lymphoma (ATLL) patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Yamasaki, Reishi
    Miyazaki, Yasushi
    Ando, Koji
    Sawayama, Yasushi
    Inoue, Yoriko
    Matsuo, Emi
    Tsutsumi, Chizuko
    Taguchi, Jun
    Imaizumi, Yoshitaka
    Imanishi, Daisuke
    Honda, Miyuki
    Fujimoto, Takeshi
    Tsushima, Hideki
    Fukushima, Takuya
    Yoshida, Shinichiro
    Honda, Sumihisa
    Hata, Tomoko
    Moriuchi, Yukiyoshi
    Tsukasaki, Kunihiro
    Tomonaga, Masao
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 586 - 586
  • [39] Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia
    Yan Chen
    Yajing Xu
    Gan Fu
    Yi Liu
    Jie Peng
    Bin Fu
    Xiaoyu Yuan
    Hongya Xin
    Yan Zhu
    Qun He
    Dengshu Wu
    Yigang Shu
    Xiaolin Li
    Xielan Zhao
    Fangping Chen
    Chinese Journal of Cancer Research, 2013, 25 (04) : 389 - 396
  • [40] Use of micafungin for antifungal prophylaxis in patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
    Lopez-Sanchez, C.
    Ruiz-Camps, I.
    Gomez, V.
    Lopez-Jimenez, J.
    Serrano, D.
    Rubio, V.
    Solano, C.
    Valcarcel, D.
    Vazquez, L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S202 - S203
12345